FDA a aprobat zanubrutinib pentru tratamentul macroglobulinemiei lui Waldenstrom

September 2021: For adult patients with Waldenström's macroglobulinemia, the FDA has approved zanubrutinib (Brukinsa, BeiGene) (WM).In ASPEN (NCT03053440), zanubrutinib was compared to ibrutinib in patients with MYD88 L265P mutat..

Beta Talasemie, BMT, Covid-19, India, talasemie

Beta Talasemia și luarea în considerare a acestuia cu COVID-19

Iulie 2021: Beta-talasemia este o afecțiune moștenită cauzată de mutații ale unei gene implicate în producerea unei componente a hemoglobinei, proteina care transportă oxigenul în tot organismul. Aceste mutații fie interzic ..

Opțiuni de tratament pentru leucemie

Because leukemia classification and prognosis stratification are complex, there is no one-size-fits-all treatment method, and it is necessary to combine careful classification and prognosis stratification to formulate treatment p..

Progresul cercetării în limfom

On June 17-20, 2015, the 13th International Lymphoma Conference was successfully held in Switzerland. 3700 representatives from 90 countries participated in the event. At the meeting, the research on lymphoma was brilliant, not o..

Povestea tratamentului în centrul de cancer MD Anderson al unui pacient cu leucemie

Eddle and Pearlie Saddler, as his wife Pearlie hopes, "enjoy a regular life" in their South Carolina town. When they rested, Saddlers volunteered and participated in the service in the church. "We go there often, especially Eddi..

Imunoterapie cu inhibitor PD-1 pentru limfomul cu celule B.

O recenzie scrisă de Young, MD, Anderson Cancer Center, SUA a explicat aplicarea imunoterapiei cu inhibitor PD-1 în limfomul cu celule B. (Sânge. Versiune online pe 8 noiembrie 2017. doi: 10.1182 / sânge-2017-07-740993.)PD-1 imunitar..

Studiul găsește idei noi pentru tratamentul leucemiei

A new study from McMaster University in Canada said that it has discovered a new treatment strategy for acute myeloid leukemia. By stimulating the production of fat cells in the bone marrow and adjusting the bone marrow microenvir..

Limfomul cu celule T periferice se confruntă cu provocări

The Cleveland Clinic of the United States Eric D. His et al. Reported that the diagnosis of peripheral T cell lymphoma (PTCL) in the United States varies greatly, and often lacks important phenotypic information to fully distingui..

Acalabrutinib, un medicament vizat de AstraZeneca, are un nou mod de a trata leucemia limfocitară cronică

Acalabrutinib is a second-generation tyrosine kinase (BTK) inhibitor, a newer drug that can improve the survival of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL).The researchers believe that BTK inhibitors comb..

Patogenia și tratamentul tumorilor cu celule T mature

Mature T-cell tumors, such as non-Hodgkin T-cell lymphoma, are highly invasive and drug-resistant, and patients often have a poor prognosis. Recently, "Nature" series of two articles published a new interpretation of the pathogene..